ACM
AIGH Capital Management Portfolio holdings
AUM
$286M
1-Year Est. Return
106.06%
1 Year Est. Return
+106.06%
AUM
$286M
AUM Growth
+$72.5M
(+34%)
Holding
52
Top Buys
| 1 | +$31.4M | |
| 2 | +$17.8M | |
| 3 | +$16.1M | |
| 4 |
Lumen
LUMN
|
+$15.6M |
| 5 |
Day One Biopharmaceuticals
DAWN
|
+$10.7M |
Top Sells
| 1 | +$21.7M | |
| 2 | +$14.7M | |
| 3 | +$11.6M | |
| 4 |
Backblaze
BLZE
|
+$9.95M |
| 5 |
Verastem
VSTM
|
+$8.31M |
Sector Composition
| 1 | Technology | 47.98% |
| 2 | Healthcare | 39.69% |
| 3 | Industrials | 6.86% |
| 4 | Communication Services | 5.46% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNDK
1
Sandisk
SNDK
$28.5B
| $31.4M | 8.85% |
+280,000
|
|
||
2
Personalis
PSNL
$903M
| $25.4M | 7.15% |
3,892,101
+168,143
|
|
||
3
Domo
DOMO
$483M
| $21.2M | 5.99% |
1,341,518
|
|
||
4
Arq
ARQ
$167M
| $18.5M | 5.2% |
2,579,486
-75,000
|
|
||
5
MaxLinear
MXL
$1.57B
| $17.8M | 5.02% |
+1,107,504
|
|
||
6
nLIGHT
LASR
$1.73B
| $17.8M | 5.01% |
600,103
|
|
||
7
Castle Biosciences
CSTL
$1.15B
| $16.1M | 4.54% |
+707,287
|
|
||
|
8
Lumen
LUMN
$9.82B
| $15.6M | 4.4% |
+2,550,000
|
|
||
9
Zevra Therapeutics
ZVRA
$491M
| $11.7M | 3.3% |
1,231,932
+313,039
|
|
||
|
10
Day One Biopharmaceuticals
DAWN
$853M
| $10.7M | 3.02% |
+1,520,492
|
|
||
11
Digital Turbine
APPS
$551M
| $9.75M | 2.75% |
+1,523,068
|
|
||
12
BK Technologies
BKTI
$242M
| $8.36M | 2.36% |
+99,009
|
|
||
13
Vishay Precision Group
VPG
$488M
| $8.01M | 2.26% |
250,000
-173,484
|
|
||
14
Esperion Therapeutics
ESPR
$896M
| $7.95M | 2.24% |
+3,000,000
|
|
||
15
Lightpath Technologies
LPTH
$379M
| $7.14M | 2.01% |
900,000
-2,742,377
|
|
||
16
Fennec Pharmaceuticals
FENC
$259M
| $6.38M | 1.8% |
681,501
+229,101
|
|
||
17
Coya Therapeutics
COYA
$129M
| $6.3M | 1.78% |
1,105,622
|
|
||
|
VELO
18
Velo3D Inc
VELO
$120M
| $5.28M | 1.49% |
+1,719,874
|
|
||
19
Phathom Pharmaceuticals
PHAT
$1.04B
| $5.05M | 1.42% |
+429,000
|
|
||
20
Ambarella
AMBA
$2.99B
| $4.13M | 1.16% |
+50,000
|
|
||
21
Talphera
TLPH
$60.6M
| $3.98M | 1.12% |
+4,454,545
|
|
||
22
PolyPid
PYPD
$65.9M
| $3.55M | 1% |
1,065,128
-128,980
|
|
||
23
RenovoRx
RNXT
$33.1M
| $3.32M | 0.94% |
2,615,193
-852,082
|
|
||
24
Larimar Therapeutics
LRMR
$297M
| $3.23M | 0.91% |
+1,000,000
|
|
||
25
Elutia
ELUT
$27.6M
| $2.82M | 0.79% |
3,165,128
-285,897
|
|